XML 111 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events (Details) - USD ($)
 1 Months Ended 2 Months Ended 9 Months Ended 10 Months Ended
Jan. 31, 2023
Jan. 08, 2023
Nov. 17, 2022
Oct. 17, 2022
May 12, 2022
Feb. 15, 2022
Jan. 10, 2022
Jan. 27, 2022
Nov. 30, 2022
Sep. 30, 2022
Dec. 31, 2020
Nov. 10, 2022
Oct. 10, 2022
Apr. 18, 2022
Apr. 11, 2022
Mar. 30, 2022
Feb. 28, 2022
Feb. 14, 2022
Dec. 31, 2021
Dec. 20, 2021
Jan. 11, 2021
Subsequent Events (Details) [Line Items]                                          
Debt instrument, repurchase amount                                     $ 51,000,000    
Preference shares, authorized                   20,000,000 20,000,000               20,000,000    
Preferred Stock, Par or Stated Value Per Share                   $ 0.0001 $ 0.0001               $ 0.0001    
Minimum net worth to consummate business combination       $ 5,000,001                                  
Funding Commitment Letter [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Line of Credit Facility, Maximum Borrowing Capacity       10,000,000                                  
Aggregate Outstanding Amount       310,000,000                                  
Sorrento [Member] | Two Thousand And Twenty Two Promissory Note [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument, term         7 years                                
Debt instrument, interest rate, stated percentage         2.66%                                
Sorrento [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument, repurchase amount                   $ 100,000,000 $ 13,700,000                 $ 51,000,000  
Scilex Pharma Note [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument, interest rate, stated percentage                     9.15%               7.70%    
Scilex Pharma Note [Member] | Subordinated Debt [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument face amount                                   $ 35,000,000      
Debt instrument, repurchase amount                                 $ 20,000,000        
Restricted cash                                 10,000,000        
Vicker's Vantage                                          
Subsequent Events (Details) [Line Items]                                          
Contribution per share                                       $ 0.75 $ 10
Sponsor loan             $ 1,035,000                            
Debt instrument face amount                           $ 500,000 $ 1,500,000         $ 500,000  
Preference shares, authorized                   1,000,000 1,000,000               1,000,000    
Preferred Stock, Par or Stated Value Per Share                   $ 0.0001 $ 0.0001               $ 0.0001    
Stock Issued During Period, Shares, Issued for Services                     25,000                    
Vicker's Vantage | Maximum [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Preference shares, authorized                   45,000,000                      
Vicker's Vantage | Minimum [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Preference shares, authorized                   20,000,000                      
Subsequent Event [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Minimum time declared to file with sec regarding resale registration statement         60 days                                
Minimum net worth to consummate business combination       5,000,001                                  
Subsequent Event [Member] | Yorkville [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Issuance of aggregate ordinary shares (in Shares)                   250,000                      
Subsequent Event [Member] | B. Riley [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Issuance of aggregate ordinary shares (in Shares) 250,000                                        
Subsequent Event [Member] | B. Riley [Member] | PurchaseType A [Member] | Scilex Common Stock Member                                          
Subsequent Events (Details) [Line Items]                                          
Shares Issued, Price Per Share $ 0.1                                        
Stock Issued During Period, Shares, Issued for Services 1,000,000                                        
Subsequent Event [Member] | B. Riley [Member] | PurchaseType B [Member] | Scilex Common Stock Member                                          
Subsequent Events (Details) [Line Items]                                          
Shares Issued, Price Per Share $ 0.25                                        
Stock Issued During Period, Shares, Issued for Services 1,000,000                                        
Subsequent Event [Member] | Standby Equity Purchase Agreement [Member] | Yorkville [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Period After Registration When The Request Could Be Made To The Investee To Purchase The Shares     36 months                                    
Maximum Percentage Of Volume Weighted Average Price Of Shares Measured On A Daily Basis That Is Eligible To Be Received As Advance     200.00%                                    
Number Of Threshold Trading Days Prior To Date Of Notice To The Shareholders For Determining The Volume Weighted Average Price Of Shares     5 days                                    
Percentage Of Daily Volume Weighted Average Price Of Shares At Which The Shares Are Eligible To Be Purchased     98.00%                                    
Number Of Consecutive Trading Days For Determining The Volume Weighted Average Price Of Shares     2 days                                    
Common stock shares subscribed but not issued value     $ 500,000,000                                    
Subsequent Event [Member] | Standby Equity Purchase Agreement [Member] | B. Riley [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Period After Registration When The Request Could Be Made To The Investee To Purchase The Shares   36 months                                      
Percentage Of Daily Volume Weighted Average Price Of Shares At Which The Shares Are Eligible To Be Purchased 98.00%                                        
Common stock shares subscribed but not issued value   $ 500,000,000                                      
Subsequent Event [Member] | Funding Commitment Letter [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Line of Credit Facility, Maximum Borrowing Capacity       10,000,000                                  
Aggregate Outstanding Amount       $ 310,000,000                                  
Subsequent Event [Member] | Series A Preferred Stock [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Preferred Stock, Par or Stated Value Per Share                       $ 0.0001                  
Subsequent Event [Member] | Maximum [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Preference shares, authorized                       45,000,000                  
Subsequent Event [Member] | Minimum [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Preference shares, authorized                       20,000,000                  
Subsequent Event [Member] | Aardvark [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Asset acquisition, consideration transferred         $ 3,000,000                                
Payments to acquire productive assets         20,000,000                                
Subsequent Event [Member] | Sorrento [Member] | Two Thousand And Twenty Two Promissory Note [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument face amount         $ 5,000,000                                
Debt instrument, term         7 years                                
Debt instrument, interest rate, stated percentage         2.66%                                
Minimum time declared to file with sec regarding resale registration statement         60 days                                
Subsequent Event [Member] | Sorrento [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Notes payable, related parties                               $ 23,000,000          
Subsequent Event [Member] | Scilex Pharma Note [Member] | Subordinated Debt [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument face amount                                   $ 35,000,000      
Debt instrument, repurchase amount                                 $ 20,000,000        
Percentage of purchase price in cash equal is to principal amount of the loan                                 100.00%        
Restricted cash                                 $ 10,000,000        
Sales threshold limit           $ 481,000,000                              
Subsequent Event [Member] | Scilex Pharma Note [Member] | Subordinated Debt [Member] | Maximum [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Debt instrument face amount           $ 28,000,000                              
Subsequent Event [Member] | Vicker's Vantage                                          
Subsequent Events (Details) [Line Items]                                          
Sponsors deposited (in Dollars)                         $ 323,889                
Common stock par value       $ 0.0001                                  
Contribution per share       $ 10     $ 0.75                            
Number of shares (in Shares)       1,500,000                                  
Warrant Exercise Price             $ 0.75                            
Additional principal amount               $ 500,000                          
Convertible Promissory Note               $ 2,035,000                          
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Liabilities assumed in a non cash transaction                 $ 11,900,000                        
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member] | Accounts Payable [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Liabilities assumed in a non cash transaction                 10,000,000                        
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member] | Accrued Liabilities [Member]                                          
Subsequent Events (Details) [Line Items]                                          
Liabilities assumed in a non cash transaction                 $ 1,900,000